Literature DB >> 20398073

Arthrodesis of the ankle and subtalar joints in patients with haemophilic arthropathy.

P G Tsailas1, J D Wiedel.   

Abstract

SUMMARY: There have been only a few studies in the literature that reported on the outcome of ankle arthrodesis in patients with haemophilia; furthermore, the number of patients was usually low and the operative technique has not been uniform. The aim of this study was to evaluate the outcome of surgery in haemophilic arthropathy of the ankle and subtalar joints, using internal fixation. From 1983 to 2006, 20 fusions were performed in 13 patients with advanced haemophilic arthropathy of the ankle and subtalar joints. There were 11 ankle fusions, one isolated subtalar fusion and eight combined ankle and subtalar fusions. Three of the latter had a subtalar fusion at a second operation. The mean age at operation was 38.7 years and the mean followup was 9.4 years. In the majority of the cases, the ankle fusion was achieved by two crossing screws. For the subtalar fusion, either staples were used or the tibiotalar screws were extended to the calcaneus. Arthrodesis of the ankle was successful in all but one patient, in whose case the procedure was revised and eventually his condition was progressed to fusion. There was also one case of painless non-union of the subtalar joint which was not revised. There was no recurrent bleeding, and no deep infection. Arthrodesis with cross screw fixation is an effective method for fusion of the ankle and subtalar joints in patients with haemophilia.

Entities:  

Mesh:

Year:  2010        PMID: 20398073     DOI: 10.1111/j.1365-2516.2010.02248.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  9 in total

1.  Risk factors associated with invasive orthopaedic interventions in males with haemophilia enrolled in the Universal Data Collection program from 2000 to 2010.

Authors:  P Tobase; H Lane; A-E-A Siddiqi; J M Soucie; R Ingram-Rich; S Ward; J C Gill
Journal:  Haemophilia       Date:  2018-06-29       Impact factor: 4.287

2.  Long-term results of ankle arthrodesis in children and adolescents with haemophilia.

Authors:  Nicolas de l'Escalopier; Alina Badina; Jean Paul Padovani; Annie Harroche; Laurent Frenzel; Philippe Wicart; Christophe Glorion; Chantal Rothschild
Journal:  Int Orthop       Date:  2017-04-20       Impact factor: 3.075

3.  Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors.

Authors:  Midori Shima; Hideji Hanabusa; Masashi Taki; Tadashi Matsushita; Tetsuji Sato; Katsuyuki Fukutake; Ryu Kasai; Koichiro Yoneyama; Hiroki Yoshida; Keiji Nogami
Journal:  Blood Adv       Date:  2017-09-27

4.  [Total ankle replacement in patients with bleeding disorders].

Authors:  A Barg; K Barg; M Wiewiorski; S W Schneider; M D Wimmer; D C Wirtz; V Valderrabano; G Pagenstert
Journal:  Orthopade       Date:  2015-08       Impact factor: 1.087

Review 5.  The Current Role of Ankle Arthrodesis in Hemophilic Patients.

Authors:  E Carlos Rodriguez-Merchan
Journal:  Arch Bone Jt Surg       Date:  2022-02

6.  Functional outcomes following ankle arthrodesis in males with haemophilia: analyses using the CDC's Universal Data Collection surveillance project.

Authors:  H Lane; A-E-A Siddiqi; R Ingram-Rich; P Tobase; R Scott Ward
Journal:  Haemophilia       Date:  2014-03-16       Impact factor: 4.287

Review 7.  Ankle hemophilic arthropathy: literature review.

Authors:  Tommaso Greco; Chiara Polichetti; Adriano Cannella; Vincenzo La Vergata; Giulio Maccauro; Carlo Perisano
Journal:  Am J Blood Res       Date:  2021-06-15

8.  Hemarthrosis subtalar, a rare diagnosis.

Authors:  Dov Lagus Rosemberg; Miguel Akkari; Susana Dos Reis Braga; Mario Lenza; Fabio Ricardo Picchi Martins; Claudio Santili
Journal:  Rev Bras Ortop       Date:  2017-03-11

9.  Tibiotalocalcaneal arthrodesis with headless compression screws.

Authors:  Ji-Cheng Gong; Bing-Hua Zhou; Xu Tao; Cheng-Song Yuan; Kang-Lai Tang
Journal:  J Orthop Surg Res       Date:  2016-08-19       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.